G1 Therapeutics Stock (NASDAQ:GTHX), Quotes and News Summary

Q: What sector and industry does G1 Therapeutics (GTHX) operate in?

G1 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

G1 Therapeutics Stock (NASDAQ: GTHX) stock price, news, charts, stock research, profile.

Open	$4.810
Close	-
Volume / Avg.	447.781K / 1.655M
Day Range	4.685 - 4.960
52 Wk Range	1.080 - 6.140
Market Cap	$254.088M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	62
Short Interest	4.68%
Days to Cover	2.99

Recent News

What's Going On With G1 Therapeutics Stock?

According to a report, G1 Therapeutics has received and rejected multiple offers from TerSera Therapeutics. According to the report, one offer from TerSera is rumored to have a contingent value right which could value the company at between $12 and $14 per share.

Erica Kollmann

Why Is Breast Cancer-Focused G1 Therapeutics Stock Trading Lower Today?

Follow G1 Therapeutics as it advances trilaciclib in Phase 3 PRESERVE 2 trial for metastatic triple-negative breast cancer. Updates on trial progress, interim analysis, and potential FDA filing in 2024.

Vandana Singh

Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Jan

Feb

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy G1 Therapeutics (GTHX) stock?

You can purchase shares of G1 Therapeutics (NASDAQ: GTHX) through any online brokerage.

View our list of the best stock brokerages.

Who are G1 Therapeutics's (GTHX) competitors?

Other companies in G1 Therapeutics’s space includes: Inovio Pharmaceuticals (NASDAQ:INO), Agenus (NASDAQ:AGEN), Monte Rosa Therapeutics (NASDAQ:GLUE), Century Therapeutics (NASDAQ:IPSC) and Design Therapeutics (NASDAQ:DSGN).

What is the target price for G1 Therapeutics (GTHX) stock?

The latest price target for G1 Therapeutics (NASDAQ: GTHX) was reported by HC Wainwright & Co. on Thursday, May 2, 2024. The analyst firm set a price target for 9.00 expecting GTHX to rise to within 12 months (a possible 85.19% upside). 17 analyst firms have reported ratings in the last year.

Current Stock Price for G1 Therapeutics (GTHX)?

The stock price for G1 Therapeutics (NASDAQ: GTHX) is $4.86 last updated Today at May 13, 2024 at 10:51 AM EDT.

Does G1 Therapeutics (GTHX) pay a dividend?

There are no upcoming dividends for G1 Therapeutics.

When is G1 Therapeutics (NASDAQ:GTHX) reporting earnings?

G1 Therapeutics’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Is G1 Therapeutics (GTHX) going to split?

There is no upcoming split for G1 Therapeutics.

What sector and industry does G1 Therapeutics (GTHX) operate in?

G1 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-